DrugPatentWatch Database Preview
Drugs in MeSH Category Neuroprotective Agents
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs | RILUZOLE | riluzole | TABLET;ORAL | 076173-001 | Jan 29, 2003 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan Technologies | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 205622-001 | Jun 20, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Novartis | EXELON | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 022083-002 | Jul 6, 2007 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||
| Pharmacia And Upjohn | MEDROL | methylprednisolone | TABLET;ORAL | 011153-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Tianjin Tianyao | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 204072-001 | May 14, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sandoz | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 087341-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
